| Title |
Calcium antagonists for aneurysmal subarachnoid haemorrhage
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2007
|
| DOI | 10.1002/14651858.cd000277.pub3 |
| Pubmed ID | |
| Authors |
Sanne Dorhout Mees, Gabriel JE Rinkel, Valery L Feigin, Ale Algra, Walter M van den Bergh, Marinus Vermeulen, Jan van Gijn |
| Abstract |
Secondary ischaemia is a frequent cause of poor outcome in patients with subarachnoid haemorrhage (SAH). Its pathogenesis has been incompletely elucidated, but vasospasm probably is a contributing factor. Experimental studies have suggested that calcium antagonists can prevent or reverse vasospasm and have neuroprotective properties. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 17% |
| United States | 1 | 17% |
| Saudi Arabia | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 332 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Romania | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 329 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 45 | 14% |
| Student > Master | 43 | 13% |
| Student > Doctoral Student | 38 | 11% |
| Student > Bachelor | 35 | 11% |
| Student > Ph. D. Student | 26 | 8% |
| Other | 63 | 19% |
| Unknown | 82 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 163 | 49% |
| Nursing and Health Professions | 20 | 6% |
| Neuroscience | 17 | 5% |
| Agricultural and Biological Sciences | 9 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
| Other | 27 | 8% |
| Unknown | 90 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2024.
All research outputs
#2,456,555
of 25,837,817 outputs
Outputs from Cochrane database of systematic reviews
#4,972
of 13,149 outputs
Outputs of similar age
#5,381
of 79,571 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 81 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,149 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 79,571 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.